[
  {
    "ts": "2026-02-22T16:21:00+00:00",
    "headline": "Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement?",
    "summary": "Merck has an attractive yield and a long history of dividend growth.",
    "url": "https://www.fool.com/investing/2026/02/22/could-merck-quietly-help-turn-steady-dividends-int/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c4451826-ae15-37d6-9858-5dbf0f97cf44",
      "content": {
        "id": "c4451826-ae15-37d6-9858-5dbf0f97cf44",
        "contentType": "STORY",
        "title": "Could Merck Stock Quietly Help Turn Steady Dividends Into a Millionaire Retirement?",
        "description": "",
        "summary": "Merck has an attractive yield and a long history of dividend growth.",
        "pubDate": "2026-02-22T16:21:00Z",
        "displayTime": "2026-02-22T16:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/299d902ea3f14e2942d2292d4694c4c9",
          "originalWidth": 1200,
          "originalHeight": 633,
          "caption": "A scientist working with a flask and beaker.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0NDbToIYmsGH6A8MbCM4ug--~B/aD02MzM7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/299d902ea3f14e2942d2292d4694c4c9.cf.webp",
              "width": 1200,
              "height": 633,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GEAqACYxvaB8IbwdLKiCqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/299d902ea3f14e2942d2292d4694c4c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/22/could-merck-quietly-help-turn-steady-dividends-int/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/could-merck-stock-quietly-help-162100713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-22T21:05:00+00:00",
    "headline": "Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades",
    "summary": "The company might bend, but it won't break.",
    "url": "https://www.fool.com/investing/2026/02/22/merck-this-cancer-drug-powerhouse-could-be-a-core/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "6dc4ff00-7f3b-3881-8057-7622aa456267",
      "content": {
        "id": "6dc4ff00-7f3b-3881-8057-7622aa456267",
        "contentType": "STORY",
        "title": "Merck: This Cancer‑Drug Powerhouse Could Be a Core Dividend Holding for Decades",
        "description": "",
        "summary": "The company might bend, but it won't break.",
        "pubDate": "2026-02-22T21:05:00Z",
        "displayTime": "2026-02-22T21:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/d2a536eb877986f5af38bd3b320fbb3c",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor and patient in a hospital room.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RXHJf8LuTey0M4UsvBoA_w--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/d2a536eb877986f5af38bd3b320fbb3c.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/krFdNHLuafSnpSDqhfhifQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/d2a536eb877986f5af38bd3b320fbb3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/22/merck-this-cancer-drug-powerhouse-could-be-a-core/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-cancer-drug-powerhouse-could-210500643.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "INTC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]